Phase 3 Ankylosing Spondylitis Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Active Ankylosing Spondylitis
Jiangsu vcare pharmaceutical technology co., LTD420 enrolled1 locationNCT07172360
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of 608 in Adult Subjects With Active Ankylosing Spondylitis(AS)
Ankylosing Spondylitis
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.500 enrolled1 locationNCT07261644
Recruiting
Phase 3
A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
Ankylosing Spondylitis
Lynk Pharmaceuticals Co., Ltd352 enrolled1 locationNCT07237568
Recruiting
Phase 3
A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo
Ankylosing Spondylitis
Tasly Pharmaceutical Group Co., Ltd408 enrolled10 locationsNCT06000956